CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

Cited by (629)

Items 101–200 of 629

1. Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
   Haroon, Ebrahim, Miller, Andrew H. · 2016 · Current Topics in Behavioral Neurosciences
2. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice
   Angela W. Corona, Diana M. Norden, John P. Skendelas, Yan Huang, Jason C. O’Connor, Marcus A. Lawson, Robert Dantzer, Keith W. Kelley, Jonathan P. Godbout · 2012 · Brain Behavior and Immunity
3. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
   Adrian L. Lopresti, Sean D. Hood, Peter D. Drummond · 2012 · Journal of Psychopharmacology
4. Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances
   Haapakoski, Rita, Ebmeier, Klaus P., Alenius, Harri, Kivimäki, Mika · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
5. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation
   Allison M. Garrison, Jennifer M. Parrott, Arnulfo Tuñon, Jennifer Delgado, Laney Redus, Jason C. O’Connor · 2018 · Psychoneuroendocrinology
6. Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback.
   Muscatell, Keely A., Moieni, Mona, Inagaki, Tristen K., Dutcher, Janine M., Jevtic, Ivana, Breen, Elizabeth C., Irwin, Michael R., Eisenberger, Naomi I. · 2016 · Brain, Behavior, and Immunity
7. Inflammation in depression: is adiposity a cause?
   Richard Charles Shelton, Andrew H. Miller · 2011 · Dialogues in Clinical Neuroscience
8. Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders
   Keith W. Kelley, Robert Dantzer · 2010 · Brain Behavior and Immunity
9. The importance of cytokines and autoantibodies in depression
   Mariana Postal, Simone Appenzeller · 2014 · Autoimmunity Reviews
10. Effect of immune activation on the kynurenine pathway and depression symptoms – A systematic review and meta-analysis
    Charlotte Hunt, Thiago Macedo e Cordeiro, Robert Suchting, Constanza de Dios, Valeria A. Cuellar, Jair C. Soares, Robert Dantzer, Antônio Lúcio Teixeira, Sudhakar Selvaraj · 2020 · Neuroscience & Biobehavioral Reviews
11. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
    Robert Dantzer, Adam K. Walker · 2014 · Journal of Neural Transmission
12. Liver-brain inflammation axis
    Charlotte D’Mello, Mark G. Swain · 2011 · American Journal of Physiology-Gastrointestinal and Liver Physiology
13. Molecular biomarkers of depression
    Anand Gururajan, Gerard A. Clarke, Timothy G. Dinan, John F. Cryan · 2016 · Neuroscience & Biobehavioral Reviews
14. Inflammation-induced depression: Its pathophysiology and therapeutic implications
    Jeon, Sang Won, Kim, Yong-Ku · 2017 · Journal of Neuroimmunology
15. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
    Jonathan B. Savitz, Robert Dantzer, Brent E. Wurfel, Teresa A. Victor, Bart N. Ford, Jerzy Bodurka, Patrick S.F. Bellgowan, T. Kent Teague, Wayne Curtis Drevets · 2014 · Psychoneuroendocrinology
16. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies
    Danilo Arnone, Smita Saraykar, Haitham Salem, Antônio Lúcio Teixeira, Robert Dantzer, Sudhakar Selvaraj · 2018 · Neuroscience & Biobehavioral Reviews
17. Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures
    Xin Fu, Samantha M. Zunich, Jason C. O’Connor, Annemieke Kavelaars, Robert Dantzer, Keith W. Kelley · 2010 · Journal of Neuroinflammation
18. Liver–brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders
    Charlotte D’Mello, Mark G. Swain · 2013 · Brain Behavior and Immunity
19. Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
    Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, Manon Lebel, Caroline Ménard · 2021 · European Journal of Neuroscience
20. Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau
    Kelly R. Jacobs, Chai K. Lim, Kaj Blennow, Henrik Zetterberg, Pratishtha Chatterjee, Ralph Nigel Martins, Bruce James Brew, Gilles J. Guillemin, David B. Lovejoy · 2019 · Neurobiology of Aging
21. Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
    Borsini, Alessandra, Alboni, Silvia, Horowitz, Mark A., Tojo, Luis M., Cannazza, Giuseppe, Su, Kuan-Pin, Pariante, Carmine M., Zunszain, Patricia A. · 2017 · Brain, Behavior, and Immunity
22. Interoception and Inflammation in Psychiatric Disorders
    Savitz, Jonathan, Harrison, Neil A. · 2018 · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
23. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, Michael Tilghman Treadway, Ebrahim Haroon, Jennifer C. Felger, Andrew H. Miller · 2021 · Pharmacological Reviews
24. Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans
    Cornelia Kiank, Jan-Philip Zeden, Solveig Drude, Grażyna Domańska, Gerhard Fusch, Winfried Otten, Christine Schuett · 2010 · PLoS ONE
25. Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
    Jennifer M. Parrott, Jason C. O’Connor · 2015 · Frontiers in Psychiatry
26. Toxicity mechanisms of arsenic that are shared with neurodegenerative diseases and cognitive impairment: Role of oxidative stress and inflammatory responses
    Claudia Escudero‐Lourdes · 2016 · NeuroToxicology
27. A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome
    Gerard A. Clarke, Declan Patrick McKernan, Gábor Gaszner, Eamonn M.M. Quigley, John F. Cryan, Timothy G. Dinan · 2012 · Frontiers in Pharmacology
28. From Stress to Anhedonia: Molecular Processes through Functional Circuits
    Colin H. Stanton, Avram J. Holmes, Steve W. C. Chang, Jutta Joormann · 2018 · Trends in Neurosciences
29. Pain and affective distress in arthritis: relationship to immunity and inflammation
    Manfred Harth, Warren R. Nielson · 2019 · Expert Review of Clinical Immunology
30. The role of the kynurenine pathway in suicidality in adolescent major depressive disorder
    Bradley, Kailyn A.L., Case, Julia A.C., Khan, Omar, Ricart, Thomas, Hanna, Amira, Alonso, Carmen M., Gabbay, Vilma · 2015 · Psychiatry Research
31. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase
    Davies, David M. Christmas, John P. Potokar · 2011 · Neuropsychiatric Disease and Treatment
32. Microbiota, immunoregulatory old friends and psychiatric disorders
    Rook, Graham A. W., Raison, Charles L., Lowry, Christopher A. · 2014 · Advances in Experimental Medicine and Biology
33. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis
    Fragoso, Yara Dadalti, Frota, Elizabeth Regina Comini, Lopes, Juarez Silva, Noal, Janaina Silveira, Giacomo, Maria Cristina, Gomes, Sidney, Gonçalves, Marcus Vinicius Magno, da Gama, Paulo Diniz, Finkelsztejn, Alessandro · 2010 · Clinical Neuropharmacology
34. Effects of inflammation on the kynurenine pathway in schizophrenia—a systematic review
    Pedraz-Petrozzi, Bruno, Elyamany, Osama, Rummel, Christoph, Mulert, Christoph · 2020 · Journal of Neuroinflammation
35. The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
    Maryam Assem, Mathilde Lando, Maria Grissi, Saı̈d Kamel, Ziad A. Massy, Jean‐Marc Chillon, Lucie Hénaut · 2018 · Toxins
36. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
    Swardfager, Walter, Herrmann, Nathan, McIntyre, Roger S., Mazereeuw, Graham, Goldberger, Kyle, Cha, Danielle S., Schwartz, Yael, Lanctôt, Krista L. · 2013 · Neuroscience & Biobehavioral Reviews
37. Depressogenic effects of medications: a review
    Christopher M. Celano, Oliver Freudenreich, Carlos G. Fernandez-Robles, Theodore A. Stern, Mario A. Caro, Jeff C. Huffman · 2011 · Dialogues in Clinical Neuroscience
38. The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
    Felger, Jennifer C. · 2016 · Current Topics in Behavioral Neurosciences
39. The kynurenine pathway in major depression: What we know and where to next
    Samara J. Brown, Xu‐Feng Huang, Kelly Anne Newell · 2021 · Neuroscience & Biobehavioral Reviews
40. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory
    Jillian M. Heisler, Jason C. O’Connor · 2015 · Brain Behavior and Immunity
41. Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge
    Parrott, Jennifer M., Redus, Laney, O’Connor, Jason C. · 2016 · Journal of Neuroinflammation
42. Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity
    Kemp, David E., Ismail-Beigi, Faramarz, Ganocy, Stephen J., Conroy, Carla, Gao, Keming, Obral, Sarah, Fein, Elizabeth, Findling, Robert L., Calabrese, Joseph R. · 2012 · Journal of Affective Disorders
43. Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression
    Qingyu Zhang, Yiming Sun, Zhang He, Ying Xin Xu, Xueting Li, Jianhua Ding, Ming Lu, Gang Hu · 2020 · Brain Behavior and Immunity
44. PRE- AND POSTNATAL EXPOSURE TO KYNURENINE CAUSES COGNITIVE DEFICITS IN ADULTHOOD
    Ana Pocivavsek, Hui Wu, Greg I. Elmer, John P. Bruno, R. Schwarcz · 2012 · European Journal of Neuroscience
45. Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine
    Raffaella Molteni, Flavia Macchi, Claudia Zecchillo, Mario Dell’Agli, E. Colombo, Francesca Calabrese, Gianluigi Guidotti, Giorgio Racagni, Marco Andrea Riva · 2013 · European Neuropsychopharmacology
46. Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
    Katrien Skorobogatov, Livia De Picker, Robert M. Verkerk, Violette Coppens, Marion Leboyer, Norbert Müller, Manuel Morrens · 2021 · Frontiers in Immunology
47. Inflammation as a treatment target in mood disorders: review
    Jones, Brett D. M., Daskalakis, Zafiris J., Carvalho, Andre F., Strawbridge, Rebecca, Young, Allan H., Mulsant, Benoit H., Husain, M. Ishrat · 2020 · BJPsych Open
48. Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study
    Arjan van Laarhoven, Sofiati Dian, Raúl Aguirre‐Gamboa, Julián Ávila-Pacheco, Isis Ricaño-Ponce, Carolien Ruesen, Jessi Annisa, Valerie A. C. M. Koeken, Lidya Chaidir, Yang Li et al. · 2018 · The Lancet Infectious Diseases
49. Exercise, Physical Activity, and Sedentary Behavior in the Treatment of Depression: Broadening the Scientific Perspectives and Clinical Opportunities
    Mats Å. Hallgren, Matthew Payton Herring, Neville G. Owen, David W. Dunstan, Örjan B. Ekblom, Björg Helgadóttir, Aya Olivia Nakitanda, Yvonne Forsell · 2016 · Frontiers in Psychiatry
50. Evidence for Inflammation-Associated Depression
    Celina S. Liu, Alexander Adibfar, Nathan Herrmann, Damien Gallagher, Krista L. Lanctôt · 2016 · Current topics in behavioral neurosciences
51. A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder
    Peng Zheng, Jianjun Chen, Ting Huang, Mingju Wang, Ying Wang, Mei-Xue Dong, Yuan-jun Huang, Lin-ke Zhou, Peng Xie · 2013 · Journal of Proteome Research
52. The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
    Hongye Liu, Lei Ding, Huifeng Zhang, David John Mellor, Haiyan Wu, Dongmei Zhao, Chuangxin Wu, Zhiguang Lin, Jiaojian Yuan, Daihui Peng · 2018 · Frontiers in Psychiatry
53. Anti-TNF-α Compounds as a Treatment for Depression
    Sarit Uzzan, Abed N. Azab · 2021 · Molecules
54. PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression
    David E. Kemp, Martha Schinagle, Keming Gao, Carla M. Conroy, Stephen J. Ganocy, Faramarz Ismail‐Beigi, Joseph R. Calabrese · 2014 · CNS Drugs
55. Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms
    Barbara Strasser, Barbara Sperner‐Unterweger, Dietmar Fuchs, Johanna Maria Gostner · 2016 · Current topics in behavioral neurosciences
56. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity
    Adriano José Maia Chaves Filho, Camila Nayane de Carvalho Lima, Silvânia Maria Mendes Vasconcelos, David Freitas de Lucena, Michael H. J. Maes, Danielle S. Macêdo · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
57. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
    Martina M. Hughes, Angela Carballedo, Declan M. McLoughlin, Francesco Amico, Andrew Harkin, Thomas Frodl, Thomas J. Connor · 2012 · Brain Behavior and Immunity
58. Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
    Masaru Tanaka, Zsuzsanna Bohár, László Vécsei · 2020 · Molecules
59. Altered kynurenine pathway metabolism in autism: Implication for immune‐induced glutamatergic activity
    C. K. Lim, M. Essa, Roberta de Paula Martins, David B. Lovejoy, Ayse A. Bilgin, M. Waly, Y. Al-Farsi, M. Al-Sharbati, Mohammed A. Al-Shaffae, G. Guillemin · 2016 · Autism Research
60. The role of the kynurenine metabolism in major depression
    Aye-Mu Myint, Markus Schwarz, Norbert Müller · 2011 · Journal of Neural Transmission
61. Pathways linking obesity to neuropsychiatric disorders
    Laís Bhering Martins, Nayara Mussi Monteze, Chadi Albert Calarge, Adaliene Versiani Matos Ferreira, Antônio Lúcio Teixeira · 2019 · Nutrition
62. Tryptophan metabolites in depression: Modulation by gut microbiota
    Iva Lukić, Sanja Ivković, Miloš Mitić, Miroslav Adžić · 2022 · Frontiers in Behavioral Neuroscience
63. Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine
    Verdonk, Franck, Petit, Anne-Cécile, Abdel-Ahad, Pierre, Vinckier, Fabien, Jouvion, Gregory, de Maricourt, Pierre, De Medeiros, Gabriela Ferreira, Danckaert, Anne, Van Steenwinckel, Juliette, Blatzer, Michael et al. · 2019 · Brain, Behavior, and Immunity
64. The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
    Francesco Bartoli, Błażej Misiak, Tommaso Callovini, Daniele Cavaleri, Riccardo Matteo Cioni, Cristina Crocamo, Jonathan B. Savitz, Giuseppe Carrà · 2020 · Molecular Psychiatry
65. Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
    Emma I Kopra, Valeria Mondelli, Carmine Maria Pariante, Naghmeh Nikkheslat · 2021 · Journal of Psychopharmacology
66. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak, Jacqueline, Doornbos, Bennard, Roest, Annelieke M., Duivis, Hester E., Vogelzangs, Nicole, Nolen, Willem A., Penninx, Brenda W.J.H., Kema, Ido P., de Jonge, Peter · 2014 · Psychoneuroendocrinology
67. Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
    Qiong Sha, Zach B. Madaj, Sarah A. Keaton, Martha L. Escobar Galvis, LeAnn Smart, Stanisław Krzyżanowski, Asgerally T. Fazleabas, Richard E. Leach, Teodor T. Postolache, Eric D. Achtyes et al. · 2022 · Translational Psychiatry
68. Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice
    Izaque de Sousa Maciel, Rodrigo B. M. Silva, Fernanda Bueno Morrone, João Β. Calixto, Maria M. Campos · 2013 · PLoS ONE
69. Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
    Shaoyi Fang, Zhibin Wu, Yali Guo, Wenjun Zhu, Chunmiao Wan, Naijun Yuan, Jianbei Chen, Wenzhi Hao, Xiaowei Mo, Xiaofang Guo et al. · 2023 · Frontiers in Immunology
70. Toxoplasma gondiiImmunoglobulin G Antibodies and Nonfatal Suicidal Self-Directed Violence
    Yuanfen Zhang, Lil Träskman‐Bendz, Shorena Janelidze, PATRICIA W. LANGENBERG, Ayman Saleh, Niel T. Constantine, Olaoluwa O. Okusaga, Cecilie Bay-Richter, Lena Brundin, Teodor T. Postolache · 2012 · The Journal of Clinical Psychiatry
71. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
    Maria Margareta Pertl, David Hevey, Noreen T. Boyle, Martina M. Hughes, Sonya Collier, Anne-Marie O’Dwyer, Andrew Harkin, M. John Kennedy, Thomas J. Connor · 2013 · Brain Behavior and Immunity
72. Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms
    Sylvie Vancassel, Lucile Capuron, Nathalie Castanon · 2018 · Frontiers in Neuroscience
73. Citalopram reduces endotoxin-induced fatigue
    Hannestad, Jonas, DellaGioia, Nicole, Ortiz, Nyrma, Pittman, Brian, Bhagwagar, Zubin · 2011 · Brain, Behavior, and Immunity
74. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
    Jonathan B. Savitz · 2016 · Current topics in behavioral neurosciences
75. Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals
    Sarah M. Clark, Ana Pocivavsek, James D. Nicholson, Francesca M. Notarangelo, PATRICIA W. LANGENBERG, Robert P. McMahon, Joel E. Kleinman, Thomas M. Hyde, John W. Stiller, Teodor T. Postolache et al. · 2016 · Journal of Psychiatry and Neuroscience
76. Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms
    Henrik Heitmann, T. Andlauer, T. Korn, M. Mühlau, P. Henningsen, B. Hemmer, M. Ploner · 2020 · Multiple Sclerosis
77. Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment
    Lotrich, Francis E, Albusaysi, Salwa, Ferrell, Robert E · 2013 · Neuropsychopharmacology
78. Serum kynurenic acid is reduced in affective psychosis
    BE Wurfel, W. Drevets, S. Bliss, J. Mcmillin, H. Suzuki, B. Ford, HM Morris, T. Teague, R. Dantzer, J. Savitz · 2017 · Translational Psychiatry
79. Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue
    Sangmi Kim, Brian J. Miller, Michael Edward Stefanek, Andrew H. Miller · 2015 · Cancer
80. Role of Inflammation in Depression and Treatment Implications
    Jennifer C. Felger · 2018 · Handbook of experimental pharmacology
81. T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
    Slyepchenko, Anastasiya, Maes, Michael, Köhler, Cristiano A., Anderson, George, Quevedo, João, Alves, Gilberto S., Berk, Michael, Fernandes, Brisa S., Carvalho, André F. · 2016 · Neuroscience & Biobehavioral Reviews
82. Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders
    J. Douglas Bremner, Nil Z. Gurel, Matthew T. Wittbrodt, Md Mobashir Hasan Shandhi, Mark Hyman Rapaport, Jonathon A. Nye, Brad D. Pearce, Viola Vaccarino, Amit Jasvant Shah, Jeanie Park et al. · 2020 · Journal of Personalized Medicine
83. Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
    Hongjie Zhu, Mikhail B. Bogdanov, Stephen H. Boyle, Wayne R. Matson, Swati Sharma, Samantha A. Matson, Erik Churchill, Oliver Fiehn, Augustus John Rush, Ranga Rama Krishnan et al. · 2013 · PLoS ONE
84. The Role of Inflammation in Brain Cancer
    James L. Sowers, Kenneth M. Johnson, Charles C. Conrad, Joel T. Patterson, Lawrence C. Sowers · 2014 · Advances in experimental medicine and biology
85. Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
    Raison, Charles L., Miller, Andrew H. · 2013 · Modern Trends in Psychiatry
86. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes
    Doolin, Kelly, Allers, Kelly A., Pleiner, Sina, Liesener, Andre, Farrell, Chloe, Tozzi, Leonardo, O’Hanlon, Erik, Roddy, Darren, Frodl, Thomas, Harkin, Andrew et al. · 2018 · Psychoneuroendocrinology
87. Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
    Michael H. J. Maes, Winfried Rief · 2012 · Psychiatry Research
88. Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
    Marc Udina, Ricard Navinés, Elfi Egmond, Giovanni Oriolo, Klaus Langohr, Dolors Giménez, M Valdés, Esther Gómez‐Gil, Iría Grande, Mónica Gratacòs et al. · 2015 · The International Journal of Neuropsychopharmacology
89. Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms
    Lucile Capuron, Nathalie Castanon · 2016 · Current topics in behavioral neurosciences
90. Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients
    Fan, Ni, Luo, Yayan, Ou, Yufen, He, Hongbo · 2017 · Human Psychopharmacology: Clinical and Experimental
91. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
    Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Mingding Li, Yuping Ning · 2018 · Brain Behavior and Immunity
92. Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
    Rickinder Sethi, Nieves Gómez‐Coronado, Adam J. Walker, Oliver D’Arcy Robertson, Bruno Agustini, Michael Berk, Seetal Dodd · 2019 · Frontiers in Psychiatry
93. Gut microbiota, kynurenine pathway and mental disorders – Review
    Magdalena Więdłocha, Piotr Marcinowicz, Marlena Janoska-Jaździk, Agata Szulc · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
94. Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults
    Barbara Strasser, Ken Berger, Dietmar Fuchs · 2014 · European Journal of Nutrition
95. Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats
    Ana Pocivavsek, Marian A. R. Thomas, Gregory I. Elmer, John P. Bruno, Robert M. Schwarcz · 2014 · Psychopharmacology
96. Depression as an evolutionary strategy for defense against infection
    Sherry L. Anders, Midori Tanaka, Dennis K. Kinney · 2012 · Brain Behavior and Immunity
97. Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
    Karolina Åkesson, Susanne Pettersson, Sara Ståhl, Izabella Surowiec, Mattias Hedenström, Susanna Eketjäll, Johan Trygg, Per‐Johan Jakobsson, Iva Gunnarsson, Elisabet Svenungsson et al. · 2018 · Lupus Science & Medicine
98. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis
    Sophie Georgin‐Lavialle, Daniela Silva Moura, Alexandre Salvador, Jean‐Christophe Chauvet‐Gélinier, Jean‐Marie Launay, Gandhi Laurent Damaj, Francine Côté, Erinn L. Soucie, Marie‐Olivia Chandesris, Stéphane Barète et al. · 2016 · Molecular Psychiatry
99. Stress-Related Immune Markers in Depression: Implications for Treatment
    Martina M. Hughes, Thomas J. Connor, Andrew Harkin · 2016 · The International Journal of Neuropsychopharmacology
100. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
     Smith, A K, Simon, J S, Gustafson, E L, Noviello, S, Cubells, J F, Epstein, M P, Devlin, D J, Qiu, P, Albrecht, J K, Brass, C A et al. · 2012 · Molecular Psychiatry